96X.F FLUOGUIDE A/S DK -1

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
2.49 EUR
Close of Nov 11, 2026
2.49 4.18
Market cap
EUR 40.7M
P/E
-
P/B
10.12x
ROE
-160.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 96X.F undervalued?

Graham number

The Graham number of FLUOGUIDE A/S DK -1 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

FLUOGUIDE A/S DK -1 fundamental analysis

No fundamental analysis for FLUOGUIDE A/S DK -1 yet.

FLUOGUIDE A/S DK -1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About FLUOGUIDE A/S DK -1

FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatment of brain cancer through photothermal and photodynamic therapies. It has a coll…

Full company profile